tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmidt, 283 are a BUY (85.5%), 48 are a HOLD (14.5%).
Analyst Michael Schmidt, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 55.89% that have a potential upside of 40.09% achieved within 287 days.
Michael Schmidt’s has documented 630 price targets and ratings displayed on 63 stocks. The coverage is on Healthcare, Technology, Consumer Defensive sectors.
Most recent stock forecast was given on GMAB, Genmab AS at 30-Oct-2026.
Analyst best performing recommendations are on IONS (IONIS PHARMACEUTICALS).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 3/27/2026. The price target of $6 was fulfilled within 14 days with a profit of $3.9 (185.71%) receiving and performance score of 132.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
4 years 4 months 29 days ago
(14-Jun-2022)
0/13 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
5 years 9 days ago
(03-Nov-2021)
12/14 (85.71%)
$0.06 (1.28%)
55
Sell Since 20-May-2020
$3
$2.91 (3233.33%)
6 years 6 days ago
(06-Nov-2020)
6/8 (75%)
$-1.26 (-29.58%)
123
Buy Since 22-Feb-2018
$16
$15.91 (17677.78%)
$17
6 years 3 months 5 days ago
(07-Aug-2020)
5/12 (41.67%)
$10.58 (195.20%)
88
Sell Since 08-Oct-2019
6 years 6 months 7 days ago
(06-May-2020)
0/2 (0%)
$25.85 (43.70%)
Which stock is Michael Schmidt most bullish on?
Which stock is Michael Schmidt most reserved on?
What Year was the first public recommendation made by Michael Schmidt?
